TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from AEVIS VICTORIA SA ( (CH:AEVS) ) is now available.
AEVIS VICTORIA SA’s Swiss Medical Network reported a significant revenue growth of over 20% in the first half of 2025, reaching CHF 501.4 million. This growth is attributed to both organic expansion and the successful integration of Spital Zofingen and CentroMedico, highlighting the effectiveness of its expansion strategy. The company continues to develop its integrated care model with the announcement of the Aare-Netz in Aargau, reinforcing its regional growth strategy.
The most recent analyst rating on (CH:AEVS) stock is a Hold with a CHF13.50 price target. To see the full list of analyst forecasts on AEVIS VICTORIA SA stock, see the CH:AEVS Stock Forecast page.
More about AEVIS VICTORIA SA
AEVIS VICTORIA SA is a diversified investment company focusing on Healthcare, Lifestyle, and Infrastructure. Its main holdings include Swiss Medical Network Holding SA, the only private clinic group in Switzerland with a presence in all three language regions, MRH Switzerland AG, a hotel chain, Infracore SA, specializing in hospital and healthcare infrastructure, Swiss Hotel Properties AG, and NESCENS SA, a brand for prevention and better-aging. AEVIS VICTORIA is listed on the SIX Swiss Exchange.
Average Trading Volume: 5,554
Technical Sentiment Signal: Sell
Current Market Cap: CHF1.13B
See more insights into AEVS stock on TipRanks’ Stock Analysis page.